-
DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded (FFPE) tissues followed by shallow whole genome sequencing
Study
EGAS50000001328
-
Identification of New Therapeutic Targets for Renal Medullary Carcinoma via Integrated Genomic and Transcriptomic Profiling
Study
EGAS50000001280
-
The evolutionary dynamics of human colorectal cancer using single-gland spatial multi-omic profiling of DNA, RNA and chromatin.
Study
EGAS00001005827
-
The evolutionary dynamics of human colorectal cancer using single-gland spatial multi-omic profiling of DNA, RNA and chromatin.
Study
EGAS00001006088
-
The evolutionary dynamics of human colorectal cancer using single-gland spatial multi-omic profiling of DNA, RNA and chromatin.
Study
EGAS00001006122
-
COMPASS Next Generation Sequencing WGS data
Study
EGAS50000001091
-
ucfDNA workflows for molecular profiling of malignant disease
Study
EGAS50000001093
-
DynaTag for efficient profiling of transcription factors in small samples and single cells
Study
EGAS50000001074
-
Liquid Biopsy Detection of Tumor-specific Structural Variants in High Grade Serous Ovarian Cancer
Study
EGAS50000001044
-
Human prostate cancer plasma cfRNA study - raw data
Study
EGAS50000001265
-
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer
Study
EGAS50000001101
-
Neuroblastoma Smart-Seq2 Single Nuclei Sequencing Data
Study
EGAS50000001103
-
DHODH is a synthetic-lethal vulnerability in BCOR-deficient acute myeloid leukemia
Study
EGAS50000001108
-
Assessing gene expression profiling from FFPE Patient Samples: A Comparison of Two Library Preparation Approaches and Recommendations
Study
EGAS50000001066
-
Sequence data to study genomic CNVs that drive apoptotic resistance and relapses on immune checkpoint inhibitors
Study
EGAS50000001055
-
p200503_fn2
Study
EGAS50000001121
-
DNA sequencing of sgRNAs enriched from the CRISPR-Cas9 screened HCC organoids
Study
EGAS50000000848
-
Delineation of the heterogeneous molecular landscape of HRS cells and their biological contributions to forming comprehensive TME ecosystems.
Study
EGAS00001008064
-
A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome
Study
EGAS50000000021
-
Quantitative analysis of a novel DNA hypermethylation panel for lung cancer diagnosis
Study
EGAS00001007008
-
NOWAC blood-based breast cancer case-control study
Study
EGAS00000000134
-
CNA differences between RNA-based subtypes of PDAC
Study
EGAS50000001218
-
Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/ HPV status
Study
EGAS50000001219
-
GOSH_Paediatric_Tumour_23P108_WSSS_WGS_Managed_Access
Study
EGAS00001007536
-
Rucaparib in patients presenting a metastatic breast cancer with Homologous Recombination Deficiency, without germline BRCA1/2 mutation, pronostic value of high LOH genomic score and predictive value of HRDetect (WGS)
Study
EGAS00001004756
-
JAK and STAT alterations in CD30 positive LPD
Study
EGAS00001004181
-
Prostate Cancer mitochondrial DNA heteroplasmies and mitochondrial gene expression
Study
EGAS00001004186
-
Genomic profiling of Rare Tumors Release 2
Study
EGAS50000000615
-
Acetalax and bisacodyl triple-negative breast cancer RNA-Seq
Study
EGAS50000000618
-
Luminal breast epithelial cells from wildtype and BRCA mutation carriers harbor copy number alterations commonly associated with breast cancer
Study
EGAS00001007716
-
Stratified Medicine Paediatrics (SMPaeds): molecular profiling of relapsed paediatric cancer
Study
EGAS50000000549
-
Breast cancer risk SNPs converge on estrogen receptor binding sites commonly shared between breast tumors to locally alter estrogen signalling output
Study
EGAS50000000008
-
EARLY DIAgnosis of PAncreatic Cancer (EARLY DIAPAC) study
Study
EGAS50000000611
-
Genetics and transcriptomics of human acute erythroid leukemia
Study
EGAS00001004203
-
Association of DNA-methylation profiles with immune responses in breast cancer patients
Study
EGAS00001004211
-
Nurminen et al ("GP2Men") Study Primary and Metastatic Prostate Cancer Whole Genome Sequence Data
Study
EGAS50000000005
-
Whole exome sequencing of pediatric soft tissue sarcoma PDX models
Study
EGAS50000000048
-
The genomic basis of childhood T-lineage acute lymphoblastic leukemia
Study
EGAS50000000016
-
Efficacy of two different FGFR-inhibitors in a patient with extrahepatic cholangiocarcinoma harboring an FGFR2 mutation
Study
EGAS50000000015
-
Identification and targeting of extremely high-risk gamma delta T-ALL in children
Study
EGAS50000000018
-
: Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumours
Study
EGAS00001004239
-
Aberrant EZHIP Expression Drives Tumorigenesis in Osteosarcoma
Study
EGAS00001007531
-
Genetic characterization of a Unique Neuroendocrine Transdifferentiation Prostate Circulating Tumor Cell - Derived eXplant (CDX) Model
Study
EGAS00001004272
-
Multidimensional Proteomics analysis of intractable cancers with prospective observational cohort for precision medicine
Study
EGAS50000000592
-
Single-Cell RNA-seq of Primary High Grade Serous Carcinoma
Study
EGAS50000000068
-
Single-cell profiling reveals mechanisms of response to anti-PD-L1 versus anti-PD-L1 combined with anti-CTLA4 in head and neck squamous cell carcinoma
Study
EGAS50000000037
-
Arcagen – thoracic malignancies
Study
EGAS50000000123
-
Converging and evolving immuno-genomic routes towards immune escape in breast cancer
Study
EGAS00001004956
-
CIRCLE-seq of PDAC PDO
Study
EGAS50000000194
-
Origination of Ovarian Cancer is Dependent on Specific Aneuploidy Landscape
Study
EGAS00001007220
-
Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years
Study
EGAS50000000001
-
Bone metastatic biopsies of breast cancer patients progressing on endocrine therapies.
Study
EGAS00001004268
-
Long-read-transcriptome-sequencing of CLL and MDS patients uncovers common molecular effects of SF3B1 mutations
Study
EGAS50000000053
-
Recording physiological history of cells with chemical labeling.
Study
EGAS50000000056
-
Multimodal epigenetic sequencing analysis for colon cancer
Study
EGAS50000000052
-
Identification of germline variants in Medullary thyroid carcinoma (MTC) by whole- exome sequencing
Study
EGAS50000000061
-
Genomic determinants of response and resistance to inotuzumab in B-ALL
Study
EGAS50000000067
-
Genomic Profiling of Pediatric Tumors by Cell Free DNA Sequencing
Study
EGAS50000000072
-
Colon cancer targeted sequencing study contaning WBCs, primary tumor tissue and plasma samples
Study
EGAS50000000059
-
Targeted sequencing (paired) of HR genes in primary and metastatic patient-derived xenografts (PDXs) of colorectal cancer (CRC)
Study
EGAS50000000075
-
A clinically and genomically annotated Early onset colorectal cancer and late onset colorectal cancer
Study
EGAS50000000544
-
Identifying mutations in patient-derived melanoma DCC lines
Study
EGAS50000001225
-
Eribulin efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models
Study
EGAS50000000152
-
Whole genome bisulfite sequencing of prostate cancer samples upon oral pimonidazole administration
Study
EGAS50000000069
-
MediMer: A versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection
Study
EGAS50000000065
-
RNA-Sequencing of cervical cancers
Study
EGAS50000000087
-
Metabolic requirements of the metastasis-initiating tumour cell population using oral squamous cell carcinoma (OSCC) as a model system
Study
EGAS00001004765
-
Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma
Study
EGAS50000000060
-
AVENIO Expanded ctDNA panel sequence alignments (BAMs) from plasma DNA of lung cancer patients from the OSCILLATE trial
Study
EGAS50000000103
-
Immunomodulatory effects and improved outcomes with cisplatin- vs carboplatin-based chemotherapy plus atezolizumab in urothelial cancer
Study
EGAS50000000104
-
Transcriptomic profiles of early and late passage metastatic colorectal cancer (mCRC) tumoroids
Study
EGAS50000000108
-
Clones derived from early passage tumoroids of colorectal cancer
Study
EGAS50000000107
-
Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)
Study
EGAS50000000130
-
Efficacy and safety of entrectinib in patients with ROS1-positive advanced/metastatic non-small cell lung cancer (NSCLC) from the Blood First Assay Screening Trial (BFAST)
Study
EGAS50000000105
-
Low-coverage whole-sequencing of metastasised colorectal cancer samples treated with bevazicumab
Study
EGAS50000000131
-
Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma.
Study
EGAS00001004320
-
Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis
Study
EGAS50000000135
-
Activating AKT1 and PIK3CA mutations in metastatic castration-resistant prostate cancer
Study
EGAS00001004328
-
SCANDARE MACARON
Study
EGAS50000000145
-
Small‑scale mutations are infrequent as mechanisms of resistance in post‑PARP inhibitor tumour samples in high grade serous ovarian cancer
Study
EGAS50000000146
-
Whole exome sequencing of bladder tumors
Study
EGAS50000001248
-
Genome-wide NanoRCS sequencing of cfDNA and ctDNA from liquid biopsies of healthy individuals and cancer patients
Study
EGAS50000000154
-
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high risk lineage ambiguous leukemia
Study
EGAS50000001255
-
Oxidative DNA damage and ubiquitin proteasome system dysfunction underpins neurodegeneration in young adults with a DNA repair disorder
Study
EGAS50000000158
-
Longitudinal copy number variation analysis from plasma DNA of head and neck cancer patients under re-radiotherapy
Study
EGAS50000000163
-
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
Study
EGAS50000000136
-
Evolutionary Trajectories of Small Cell Lung Cancer under Therapy
Study
EGAS50000000169
-
Single-cell transcriptomic analyses of peripheral blood mononuclear cells, peritoneal fluid, and peritoneal metastases from patients with colorectal cancer
Study
EGAS50000000173
-
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
Study
EGAS50000000168
-
Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals
Study
EGAS50000000179
-
Exome sequencing of early and late passage Patient Derived Xenogratf Tumoroids with matched Patient Derived Xenogratfs and matched normal liver
Study
EGAS50000000185
-
Oxidative DNA damage and ubiquitin proteasome system dysfunction underpins neurodegeneration in young adults with a DNA repair disorder
Study
EGAS50000000160
-
Oxidative DNA damage and ubiquitin proteasome system dysfunction underpins neurodegeneration in young adults with a DNA repair disorder
Study
EGAS50000000162
-
Origin of second malignancies in children
Study
EGAS50000000167
-
Karyotype Evolution in Response to Chemoradiotherapy and Upon Recurrence of Esophageal Adenocarcinomas
Study
EGAS00001007711
-
Shallow Whole Genome Sequencing of Patient Derived Xenografts
Study
EGAS50000000191
-
Microbiome confounders and quantitative profiling challenge established microbial targets in colorectal cancer developmental stages
Study
EGAS00001007413
-
cell-Free DNA Genomic Profiling and its Clinical Implementation in Advanced Prostate Cancer
Study
EGAS50000000234
-
Comprehensive spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Study
EGAS50000000220
-
Single-cell atlas of penile cancer reveals TP53 mutations as driver for an aggressive phenotype, irrespective of HPV status, and provides clues for treatment personalization
Study
EGAS50000000217